Lipid nanoparticles for oral delivery of raloxifene: Optimization, stability, in vivo evaluation and uptake mechanism

被引:123
作者
Ravi, Punna Rao [1 ]
Aditya, N. [1 ]
Kathuria, Himanshu [1 ]
Malekar, Srinivas [1 ]
Vats, Rahul [1 ]
机构
[1] BITS Pilani Hyderabad Campus, Dept Pharm, Hyderabad, Andhra Pradesh, India
关键词
Raloxifene HCl; Solid lipid nanoparticle; Box-Bhenken design; Design of experiments; Everted gut sac; Lymphatic transport; Glyceryl behenate; BIODEGRADABLE POLYMERIC MICROSPHERES; INTESTINAL LYMPHATIC TRANSPORT; FLOW BLOCKING APPROACH; DRUG-DELIVERY; PHARMACOKINETICS; BIOAVAILABILITY; ABSORPTION; RELEASE; RATS; GLUCURONIDATION;
D O I
10.1016/j.ejpb.2013.12.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Raloxifene HCI (RLX) shows low oral bioavailability (<2%) in humans due to poor aqueous solubility and extensive (>90%) metabolism in gut. Lipid nanoparticles (SLN) with glyceryl tribehenate were designed to enhance drug's oral bioavailability. Box-Bhenken design was used to optimize manufacturing conditions. Optimized SLN had particle size of 167 +/- 3 nm and high encapsulation efficiency (>92%). Oral bioavailability of RLX from SLN was improved by 3.24 folds compared to free RLX in female Wistar rats. Both clathrin and caveolae mediated endocytosis pathways were involved in the uptake of SLN. Lymphatic transport inhibitor, cycloheximide significantly reduced oral bioavailability of SLN. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:114 / 124
页数:11
相关论文
共 40 条
[1]   The improved everted gut sac: a simple method to study intestinal P-glycoprotein [J].
Barthe, L ;
Bessouet, M ;
Woodley, JF ;
Houin, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 173 (1-2) :255-258
[2]   Gastrointestinal absorption of drugs: methods and studies [J].
Barthe, L ;
Woodley, J ;
Houin, G .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1999, 13 (02) :154-168
[3]   Kinetic analysis of drug release from nanoparticles [J].
Barzegar-Jalali, Mohammad ;
Adibkia, Khosro ;
Valizadeh, Hadi ;
Shadbad, Mohammad Reza Siahi ;
Nokhodchi, Ali ;
Omidi, Yadollah ;
Mohammadi, Ghobad ;
Nezhadi, Somayeh Hallaj ;
Hasan, Maryam .
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2008, 11 (01) :167-177
[4]   Enhanced intestinal absorption and bioavailability of raloxifene hydrochloride via lyophilized solid lipid nanoparticles [J].
Burra, Madhu ;
Jukanti, Raju ;
Janga, Karthik Yadav ;
Sunkavalli, Sharath ;
Velpula, Ashok ;
Ampati, Srinivas ;
Jayaveera, K. N. .
ADVANCED POWDER TECHNOLOGY, 2013, 24 (01) :393-402
[5]   Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry [J].
Castelli, F ;
Puglia, C ;
Sarpietro, MG ;
Rizza, L ;
Bonina, F .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 304 (1-2) :231-238
[6]   Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs [J].
Dahan, A ;
Hoffman, A .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 24 (04) :381-388
[7]   Human Pharmacokinetic Prediction of UDP-Glucuronosyltransferase Substrates with an Animal Scale-Up Approach [J].
Deguchi, Tsuneo ;
Watanabe, Nobuaki ;
Kurihara, Atsushi ;
Igeta, Katsuhiro ;
Ikenaga, Hidenori ;
Fusegawa, Keiichi ;
Suzuki, Norio ;
Murata, Shinji ;
Hirouchi, Masakazu ;
Furuta, Yoshitake ;
Iwasaki, Masaru ;
Okazaki, Osamu ;
Izumi, Takashi .
DRUG METABOLISM AND DISPOSITION, 2011, 39 (05) :820-829
[8]   Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: Performance and mechanism [J].
Gao, Fang ;
Zhang, Zhiwen ;
Bu, Huihui ;
Huang, Yan ;
Gao, Zhiwei ;
Shen, Jianan ;
Zhao, Chunjie ;
Li, Yaping .
JOURNAL OF CONTROLLED RELEASE, 2011, 149 (02) :168-174
[9]  
Golomb B A., 2008, Peripheral Arterial Disease, V2nd, P1
[10]   Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting [J].
Göppert, TM ;
Müller, RH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 302 (1-2) :172-186